Nanjing Ange Pharmaceutical

This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (November 2008) (Learn how and when to remove this template message)

Nanjing Ange Pharmaceutical Co., Ltd. (simplified Chinese: 南京安格医药化工有限公司; traditional Chinese: 南京安格醫藥化工有限公司; pinyin: Nánjīng āngé yīyào huàgōng yǒuxiàn gōngsī) is a pharmaceutical company in Nanjing, in the People's Republic of China, specializing in the development of “New Drugs” (the drugs that previously have not been marketed in China, i.e., New Chemical Entities for China's FDA) as well as the research, development, production and trade of chemical APIs and pharmaceutical intermediates.^[1]

Company Profile[]

Ange was founded in 2003, and is now a leading company in the Chinese pharmaceutical industry. With almost every major university in Nanjing Ange has established cooperative relationships and laboratories, including China Pharmaceutical University, China's first independent school of pharmacy and one of the few institutes with complete pharmaceutical fields.^{[citation needed]}

Main Products[]

Ange's main products are Antineoplastic medicines, which include:

• Sunitinib
• Lapatinib
• Nilotinib
• Dasatinib
• Gefitinib
• Erlotinib
• Imatinib
• Canertinib

It also produces relative pharmaceutical intermediates.

Recent Projects[]

In the past 2 years, Ange has been working with Abbott Laboratories Ltd. and Simcere Pharmaceutical Group, etc.^{[citation needed]}

References[]

External links[]

• Ange Official Web Site (in English)